Indication
Treatment of patients with hormone refractory metastatic prostate cancer previously treated with a docetaxel-containing regimen.
Loading your page…
Loading your page…
Prostatic Neoplasms, Castration-Resistant
Marketing Authorisation Holder: Accord Healthcare S.L.U.
EMA Authorisation: 28/08/2020
INN: cabazitaxel
AI Drug & Interaction Analysis
Free account required
Ask Osler about Cabazitaxel Accord: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.